Bionano Genomics Company

BioNano Genomics develops nanoscale imaging and analytic platforms designed to analyze DNA and other genome-related peptides and proteins.

Funding Status: IPO
Headquarters: San Diego, California, United States
Founded Date: 01.01.2003
Investor Type: N/A
Investment Stage: N/A
Technology: Сancer Diagnostics
Employee Number: 11-50
Number Of Exists: N/A
Estimated Revenue: $1M to $10M
Industry: Deep Diagnostics